Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Acquisitions (2021)

Beam Therapeutics (BEAM) has disclosed Acquisitions for 1 consecutive years, with $620000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Acquisitions changed N/A to $620000.0 in Q1 2021 year-over-year; TTM through Dec 2021 was $620000.0, a N/A change, with the full-year FY2025 number at $78000.0, changed N/A from a year prior.
  • Acquisitions was $620000.0 for Q1 2021 at Beam Therapeutics.
  • In the past five years, Acquisitions ranged from a high of $620000.0 in Q1 2021 to a low of $620000.0 in Q1 2021.